Skip to main content
An official website of the United States government

Chemopreventive Agent Development

Designs, develops, implements, and monitors research on interventions that may block, reverse, or delay the early stages of cancer. Investigates nutrients, micronutrients, natural products, pharmacologic agents, biomolecules, and vaccines from preclinical to early-phase I clinical studies. Helps investigators to bridge the gaps between biology and identifying potential targets, and between discovery of targets and agents and clinical testing in people.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

Major Programs

Staff List

Photo Name, Email, Phone Room Group(s)/Office
Asefa, Wosene
wosene.asefa@nih.gov
240-276-6422
5E504 Program Support Assistant | Chemopreventive Agent Development
Biswas, Kajal, Ph.D.
kajal.biswas2@nih.gov
240-276-5614
5E540 Program Officer | Chemopreventive Agent Development
Cholewa, Brian, Ph.D.
brian.cholewa@nih.gov
240-276-7545
5E446 Deputy Chief | Chemopreventive Agent Development
Clifford, John, Ph.D.
john.clifford@nih.gov
202-235-4482
5E430 Program Officer | Chemopreventive Agent Development
Gunasekharan, Vignesh, Ph.D.
vignesh.gunasekharan@nih.gov
240-276-5814
5E438 Program Officer | Chemopreventive Agent Development
Mohammed, Altaf, Ph.D.
altaf.mohammed@nih.gov
240-276-6082
5E542 Deputy Chief | Chemopreventive Agent Development
Nalli, Ancy, Ph.D., M.S.
ancy.nalli@nih.gov
202-276-5265
5E536 Program Officer | Chemopreventive Agent Development
Sei, Shizuko, M.D.
shizuko.sei@nih.gov
240-276-5005
5E452 Co-Chief | Chemopreventive Agent Development
Shoemaker, Robert, Ph.D.
robert.shoemaker@nih.gov
240-276-7077
5E454 Co-Chief | Chemopreventive Agent Development
Acting Chief | Nutritional Science
Vlad, Anda, M.D., Ph.D.
anda.vlad@nih.gov
240-276-6422
5E538 Program Officer | Chemopreventive Agent Development

Grants

PI Name Sort descending PI Organization Title Grant Number Program Official
Wang, Thomas D

University Of Michigan At Ann Arbor
United States

Early detection of colorectal cancer in the traditional and serrated pathways 5R01CA249851-05 Guillermo Marquez, Ph.D.
Wang, Kai

Massachusetts General Hospital
United States

Dietary prevention for colorectal cancer: targeting the bile acid/gut microbiome axis 4R00CA283146-03 Amit Kumar, Ph.D.
Wang, Tza-Huei Jeff

Johns Hopkins University
United States

Development of a low-cost epigenetic screening assay for Pap specimen-based detection of early-stage ovarian cancer in high-risk women 5R01CA260628-05 Christos Patriotis, Ph.D., M.Sc.
Wang, Thomas D

University Of Michigan At Ann Arbor
United States

Peptide multimer for early detection of hepatocellular carcinoma 5R01CA285303-02 Guillermo Marquez, Ph.D.
Wang, Hsiao-Lan

University Of Alabama At Birmingham
United States

A Motion Exergaming Approach to Promote Self-Managing Fatigue and Pain after Head and Neck Cancer Treatment 5R01CA244947-06 Goli Samimi, Ph.D., M.P.H.
Wang, Tza-Huei Jeff

Johns Hopkins University
United States

A low-cost, multiplexed digital high resolution melt platform for DNA methylation-based detection and identification of cancers in liquid biopsies 5R33CA272321-03 Christos Patriotis, Ph.D., M.Sc.
Wang, Linghua

University Of Tx Md Anderson Can Ctr
United States

Center for Gastric Pre-Cancer Atlas of Multidimensional Evolution in 3D (GAME3D) 4U01CA294518-02 Indu Kohaar, Ph.D., M.Phil., M.Sc.
Wang, Jing

New York University School Of Medicine
United States

Optimizing the use of ketamine to reduce chronic postsurgical pain 3UH3CA261067-05S1 Brennan Streck, Ph.D., RN, M.P.H.
Warner, Erica T

Massachusetts General Hospital
United States

Aspirins legacy on cancer and overall benefit: risk balance over a 15-year horizon 3U01CA301988-02S1 Asad Umar, D.V.M., Ph.D.
Washington, Karla

Washington University
United States

Problem-Solving Therapy for Cancer Caregivers: A Randomized Clinical Trial in Outpatient Palliative Care 5R01CA258311-05 Brennan Streck, Ph.D., RN, M.P.H.
Watt, Gordon Patrick

Netherlands Cancer Institute
United States

Quantitative background parenchymal enhancement, measured on contrast-enhanced mammogram, as a novel marker of breast cancer risk 3R37CA284134-03S1 Claire Zhu, Ph.D.
Webster, Nicholas J

University Of California, San Diego
United States

Time-restricted feeding and breast cancer 5R01CA196853-09 Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Webster, Nicholas J

Veterans Medical Research Fdn/San Diego
United States

The Effect of Time-Restricted Eating on the Efficiency of Chemo- and Hormonal-Therapy in Breast Cancer 5R21CA288777-02 Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Wei, Lei

Roswell Park Cancer Institute Corp
United States

Advancing skin cancer prevention by tackling UV-induced clonogenic mutations 5R01CA255242-05 Wendy Wang, Ph.D., M.Sc.
Welsh, Joellen

State University Of New York At Albany
United States

Vitamin K: Body Pools and Function in Breast Cancer 5R01CA258231-05 Young Kim, Ph.D.